Your browser doesn't support javascript.
loading
ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?
Zhu, Baohui; Ouda, Ryota; de Figueiredo, Paul; Kobayashi, Koichi S.
Afiliação
  • Zhu B; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Ouda R; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • de Figueiredo P; Christopher S. Bond Life Sciences Center, Department of Molecular Microbiology and Immunology, and Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA.
  • Kobayashi KS; Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Expert Opin Ther Targets ; 27(8): 639-644, 2023.
Article em En | MEDLINE | ID: mdl-37602463
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article